Allarity Therapeutics: Funding, Investors & Team (Sep 2026)
Allarity Therapeutics is a biopharmaceutical company that focuses on creating cancer treatments that are personalized to each patient. They use advanced technology to predict how patients will respond to different drugs, which helps improve the selection process and outcomes of clinical trials. The company's product pipeline includes several promising treatments such as Dovitinib, which is used to treat renal cell carcinoma, Stenoparib, a dual PARP inhibitor, and Tankyrase Inhibitor, which targets ovarian cancer. They also develop IXEMPRA, a microtubulin inhibitor that is effective in treating metastatic breast cancer.
Allarity Therapeutics has raised $31.0M across 2 funding rounds on record, the most recent an undisclosed round of $20.0M announced in Mar 2026.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Allarity Therapeutics Company Profile and Key Stats
Latest funding round on record: Mar 2026.
Allarity Therapeutics Funding Rounds
Allarity Therapeutics raised $11.0M in an undisclosed round announced in Jul 2023.
2.7 years later, an undisclosed round of $20.0M was announced in Mar 2026.
Allarity Therapeutics Founders and Leadership Team
Contact details for the Allarity Therapeutics team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Allarity Therapeutics Funding Compared to Other Biotechnology Startups
Allarity Therapeutics' latest round of $20.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Allarity Therapeutics in Biotechnology and Boston
Companies Similar to Allarity Therapeutics
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Allarity Therapeutics Funding FAQs
What does Allarity Therapeutics do?
Allarity Therapeutics is a biopharmaceutical company that focuses on creating cancer treatments that are personalized to each patient. They use advanced technology to predict how patients will respond to different drugs, which helps improve the selection process and outcomes of clinical trials. The company's product pipeline includes several promising treatments such as Dovitinib, which is used to treat renal cell carcinoma, Stenoparib, a dual PARP inhibitor, and Tankyrase Inhibitor, which targets ovarian cancer. They also develop IXEMPRA, a microtubulin inhibitor that is effective in treating metastatic breast cancer.
How much funding has Allarity Therapeutics raised?
Allarity Therapeutics has raised $31.0M across 2 rounds on record. The most recent is an undisclosed round of $20.0M announced in Mar 2026.
When did Allarity Therapeutics last raise funding?
Allarity Therapeutics' most recent funding round on record is an undisclosed round of $20.0M, announced in Mar 2026.
Who founded Allarity Therapeutics?
FundedIQ lists Steen Knudsen (Founder), Thomas Jensen (Founder) at Allarity Therapeutics.
Where is Allarity Therapeutics headquartered?
Allarity Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Allarity Therapeutics have?
Allarity Therapeutics is in the 11-50 employee band.
How does Allarity Therapeutics' funding compare to other Biotechnology startups?
Allarity Therapeutics' latest round of $20.0M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Allarity Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Allarity Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.